Picture
South San Francisco, US · Founded 2022 · Delaware corporation · 5 known investors
NOETIK builds AI and computational biology platforms to discover and develop cancer therapeutics by combining large-scale multimodal spatial biology data from human tumors with machine learning models. The company serves pharmaceutical and biotech researchers developing cancer drugs, particularly focused on precision oncology and immunotherapy.
Founders & leadership
JR
Jacob RinaldiExecutive Officer, Director, Promoter
RA
Ronald AlfaExecutive Officer, Director, Promoter
SH
SVP, Head of Research at RecursionCo-founder
VO
VP of Informatics at Parker Institute for Cancer ImmunotherapyCo-founder
CC
Chief Corporate Development Officer at RecursionCo-founder
JH
James HardimanDirector
AS
Amy SchulmanDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$40MraisedAug 2024 · 20 investors · BiotechnologyRule 506(b)
▶$40MraisedAug 2024 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James HardimanDirector
- Jacob RinaldiExecutive Officer, Director, Promoter
- Ronald AlfaExecutive Officer, Director, Promoter
- Amy SchulmanDirector
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$8MraisedSep 2022 · 9 investors · BiotechnologyRule 506(b)
▶$8MraisedSep 2022 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ronald AlfaExecutive Officer, Director, Promoter
- Jacob RinaldiExecutive Officer, Director, Promoter
- James HardimanDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.